These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27372056)

  • 1. The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database.
    Liatis S; Dafoulas GE; Kani C; Politi A; Litsa P; Sfikakis PP; Makrilakis K
    Diabetes Res Clin Pract; 2016 Aug; 118():162-7. PubMed ID: 27372056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
    Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
    Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
    Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet.
    Bachmann KN; Roumie CL; Wiese AD; Grijalva CG; Buse JB; Bradford R; Zalimeni EO; Knoepp P; Dard S; Morris HL; Donahoo WT; Fanous N; Fonseca V; Katalenich B; Choi S; Louzao D; O'Brien E; Cook MM; Rothman RL; Chakkalakal RJ
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00637. PubMed ID: 32881317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists.
    Payk SL; Drew RH; Smith JD; Jiroutek MR; Holland MA
    Clin Ther; 2015 Jul; 37(7):1477-1482.e1. PubMed ID: 26024569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019.
    Lee KA; Jin HY; Kim YJ; Im YJ; Kim EY; Park TS
    J Korean Med Sci; 2021 Sep; 36(36):e230. PubMed ID: 34519186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the development of metformin and sulfonylurea prescriptions in the Czech Republic].
    Janíčková-Žďarská D; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S25-9. PubMed ID: 26652962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J; Coupland C
    BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidiabetic drugs prescription patterns among a group of patients in Colombia].
    Machado Alba JE; Moncada Escobar JC; Mesa Escobar G
    Rev Panam Salud Publica; 2007 Aug; 22(2):124-31. PubMed ID: 17976279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
    Montvida O; Shaw J; Atherton JJ; Stringer F; Paul SK
    Diabetes Care; 2018 Jan; 41(1):69-78. PubMed ID: 29109299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of use of diabetic medication and clinical guidelines in four Nordic countries.
    Järvinen S; Laine MK; Eriksson JG
    Ann Med; 2016; 48(3):162-8. PubMed ID: 26890317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.
    Kwon CS; Seoane-Vazquez E; Rodriguez-Monguio R
    BMC Health Serv Res; 2018 Feb; 18(1):78. PubMed ID: 29391064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How many and who are receiving medication for diabetes mellitus?].
    Strøm H; Engeland A; Eriksen E; Sakshaug S; Rønning M
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):768-70. PubMed ID: 16541171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015.
    Wang X; Cao Y; Wu Y; Yang C; Song J; Tian Y; Wang M; Li M; Wu Y; Hu Y
    Medicine (Baltimore); 2019 Feb; 98(8):e14370. PubMed ID: 30813137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia.
    Nyström T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
    Diabetes Res Clin Pract; 2017 Jan; 123():199-208. PubMed ID: 28056431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort analysis of hypoglycaemic and cardiovascular agent use in young adults in the Irish primary care setting.
    Grimes RT; Bennett K; Hoey H; Tilson L; Henman MC
    Ir J Med Sci; 2017 May; 186(2):461-470. PubMed ID: 27534545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
    Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
    Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antidiabetic drugs in the U.S., 2003-2012.
    Hampp C; Borders-Hemphill V; Moeny DG; Wysowski DK
    Diabetes Care; 2014; 37(5):1367-74. PubMed ID: 24623020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.